| Size | Price | Stock | Qty |
|---|---|---|---|
| 10g |
|
||
| 25g |
|
||
| Other Sizes |
| Targets |
Benzoylcholine chloride acts as a cholinergic receptor ligand due to its structural similarity to acetylcholine. As a quaternary ammonium compound, it can interact with nicotinic and muscarinic acetylcholine receptors. The compound is used in pharmacological research to study cholinergic signaling pathways and receptor function. It serves as a tool compound for investigating the structure-activity relationships of cholinergic agonists and antagonists.
|
|---|---|
| ln Vitro |
In vitro studies have characterized benzoylcholine chloride as a cholinergic receptor ligand. The compound is evaluated in receptor binding assays using membrane preparations expressing cholinergic receptors. Functional assays may measure receptor activation using calcium imaging, electrophysiological recordings, or second messenger detection systems. The compound's activity is typically compared to acetylcholine and other cholinergic agonists.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for benzoylcholine chloride as a therapeutic agent. The compound is used as a research tool in pharmacological studies. If used in animal studies, it would be administered via appropriate routes to study cholinergic effects. Dosing and administration protocols would follow standard procedures for cholinergic compounds with appropriate monitoring for adverse effects.
|
| Enzyme Assay |
For non-cellular assays, benzoylcholine chloride is characterized by standard analytical techniques including NMR, HPLC, and mass spectrometry to confirm identity and purity. The compound can be evaluated in receptor binding assays using radioligand displacement techniques. Typical protocols involve incubating the compound with membrane preparations expressing cholinergic receptors and a radiolabeled ligand. Binding affinity is calculated from competition curves. Purity is typically ≥98.0% by nonaqueous titration.
|
| Cell Assay |
For in vitro cell-based studies, benzoylcholine chloride is dissolved in DMSO or aqueous buffers and diluted in cell culture medium to appropriate concentrations. Cells expressing cholinergic receptors (such as neuronal cell lines or transfected cells) are treated with the compound to assess receptor activation. Functional assays may measure calcium mobilization, electrophysiological responses, or downstream signaling events. Appropriate controls including acetylcholine as a positive control should be included.
|
| Animal Protocol |
For in vivo animal studies, benzoylcholine chloride can be administered via various routes including intravenous, intraperitoneal, or intramuscular injection. Dosing solutions should be prepared fresh using appropriate vehicles such as saline. The compound should be handled with care due to its pharmacological activity. Dosing regimens and administration protocols should follow approved animal welfare guidelines and institutional protocols for cholinergic studies.
|
| ADME/Pharmacokinetics |
Benzoylcholine chloride has a molecular weight of 243.73 and molecular formula C12H18ClNO2. It is a white to almost white powder to crystalline solid that is soluble in water. Storage: room temperature in a cool and dark place (<15°C), under inert gas, protected from moisture. Purity: ≥98.0% by nonaqueous titration. The compound is hygroscopic and should be stored in a sealed container.
|
| Toxicity/Toxicokinetics |
Benzoylcholine chloride is for research use only and not for human consumption. As a cholinergic compound, it may have pharmacological effects if absorbed. Standard laboratory safety practices should be followed when handling this chemical. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD50 values and detailed toxicological profiles have not been extensively reported.
|
| Additional Infomation |
Benzoylcholine chloride (CAS 2964-09-2) is also known as [2-(benzoyloxy)ethyl]trimethylazanium chloride and 2-benzoyloxyethyl(trimethyl)azanium chloride. It has a Beilstein Registry Number of 9173 and MDL number MFCD00011786. The compound is structurally related to acetylcholine and is used as a research chemical for cholinergic receptor studies. No clinical trials or therapeutic approvals exist.
|
| Molecular Formula |
C12H18CLNO2
|
|---|---|
| Molecular Weight |
243.73
|
| Exact Mass |
243.102
|
| CAS # |
2964-09-2
|
| PubChem CID |
76298
|
| Appearance |
White to off-white solid powder
|
| Melting Point |
204-208 °C
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
16
|
| Complexity |
202
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[Cl-].O(C(C1C([H])=C([H])C([H])=C([H])C=1[H])=O)C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]
|
| InChi Key |
QVFHQENRNSAHEK-UHFFFAOYSA-M
|
| InChi Code |
InChI=1S/C12H18NO2.ClH/c1-13(2,3)9-10-15-12(14)11-7-5-4-6-8-11;/h4-8H,9-10H2,1-3H3;1H/q+1;/p-1
|
| Chemical Name |
2-benzoyloxyethyl(trimethyl)azanium;chloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~100 mg/mL (~410.3 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 5 mg/mL (20.51 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (50.0 mg/mL) to 400 μL of PEG300 and mix well; then add 50 μL of Tween-80 and mix well; finally add 450 μL of physiological saline and adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 5 mg/mL (20.51 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (50.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.1029 mL | 20.5145 mL | 41.0290 mL | |
| 5 mM | 0.8206 mL | 4.1029 mL | 8.2058 mL | |
| 10 mM | 0.4103 mL | 2.0515 mL | 4.1029 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
